You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ATENOLOL AND CHLORTHALIDONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Atenolol And Chlorthalidone, and when can generic versions of Atenolol And Chlorthalidone launch?

Atenolol And Chlorthalidone is a drug marketed by Aurobindo Pharma Usa, Nostrum Labs, Novitium Pharma, Pliva, Sun Pharm Industries, Twi Pharms, Unichem, Watson Labs, and Zydus Pharms. and is included in nine NDAs.

The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Atenolol And Chlorthalidone

A generic version of ATENOLOL AND CHLORTHALIDONE was approved as atenolol; chlorthalidone by TWI PHARMS on May 31st, 1990.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ATENOLOL AND CHLORTHALIDONE?
  • What are the global sales for ATENOLOL AND CHLORTHALIDONE?
  • What is Average Wholesale Price for ATENOLOL AND CHLORTHALIDONE?
Summary for ATENOLOL AND CHLORTHALIDONE
Drug patent expirations by year for ATENOLOL AND CHLORTHALIDONE
Recent Clinical Trials for ATENOLOL AND CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federico II UniversityPhase 4
Agenzia Italiana del FarmacoPhase 4
VA Office of Research and Development

See all ATENOLOL AND CHLORTHALIDONE clinical trials

Pharmacology for ATENOLOL AND CHLORTHALIDONE

US Patents and Regulatory Information for ATENOLOL AND CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Usa ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074203-001 Oct 31, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 210028-002 Mar 8, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pliva ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074107-001 Sep 24, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nostrum Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074404-002 May 14, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Twi Pharms ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 072302-001 May 31, 1990 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pliva ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074107-002 Sep 24, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.